Skip to content
OpenCapital
Get started

Balchem BCPC Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price at other companies

Perimeter Solutions logo
Perimeter SolutionsPRM
——
Merck & Co. logo
Merck & Co.MRK
——

Other financials

Income statement

See full
Revenue$270.7M+8.1%
Gross profit$101.1M+14.6%
Operating income$55.6M+9.0%
Net income$40.3M+8.7%
EPS (diluted)$1.25+10.6%

Balance sheet

See full
Cash & equivalents$72.9M+46.0%
Total debt$37.4M-1.7%
Total equity$1.3B+6.3%
Total assets$1.7B+4.7%

Cash flow

See full
Operating cash flow$40.1M+9.9%

Valuation

See full
Market cap$5.33B+0.5%
Enterprise value$5.3B+0.1%
P/E33.7×-5.1×
P/S5×-0.5×

Profitability

See full
Gross margin36.3%+0.7pp
Operating margin20.2%+0.3pp
Net margin15%+0.8pp
FCF margin14.9%—

Returns & leverage

See full
Return on equity12.7%+0.7pp
Debt / equity0×0.0×
Current ratio2.5×+0.1×

Where this comes from

Reported directly by Balchem in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.

The official record: Balchem’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Balchem's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Balchem's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Balchem (BCPC) reported share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price of $126.38 in Q1 2026.
How has Balchem's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price changed year-over-year?
Balchem's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price increased by 7.5% year-over-year, from $117.53 to $126.38.
What is the long-term trend for Balchem's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Over 4 years (2021 to 2025), Balchem's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price has grown at a 8.1% compound annual growth rate (CAGR), from $88.19 to $120.48.